Partneringdesk - essential information for
partnership decisions

Partneringdesk offers a range of innovative products that provide solutions to your business intelligence partnering needs including essential access to biopharma deal announcements as they happen and the latest market and business intelligence reports from the leading publishers worldwide.

• Early Stage and Discovery Deals
• Partneringdesk Deals and Alliances Therapy Reports
• Partneringdesk Deals Briefings
• Partnering Review 2006
• Reports

Understand the benefits and structures of early stage deals

By 2010 major pharmaceutical companies are forecast to make between 40% and 50% of their revenues from in-licensed products. More and more of those licensing deals are now done at the early stages of development – ChemoCentryx, for example, has signed a drug discovery and development deal with GSK that could be worth $1.5 billion.

Products that are licensed-in, even at an early stage, have a lower failure rate than in-house projects and early stage partnering is now a core component of both biotech and pharmaceutical business strategy. Success means understanding the changing dynamics and increasing complexity of early-stage deal making trends – and this new report can help you to do just that.

It includes:

A complete analysis of deal making trends
Benefits of early stage deals
Deal structures and partnering models
Deal valuations
Payment terms and strategies

The report has been fully updated for the second edition and includes case studies from 2006, the reasons why in-licensed projects succeed and the cost difference between licensed and in-house projects.

DOWNLOAD THE TABLE OF CONTENTS Click for PDF file.

£1385 ($2695)
For further information about these reports, please contact Marianne O'Neill on +44 (0)1256 336632
or moneill@biopharmkp.com

Click here to order

Partneringdesk Deals and Alliances Therapy Reports

Partneringdesk Deals and Alliances provides an in-depth view of deals and alliances announced in 14 therapy areas between 2001 and 2006, in a clear and accessible PDF format.

The reports contain:
• fully categorized deal overviews
• financial information where disclosed
• company profiles of the top 25 dealmakers in the report
• specialized indexes by company, development stage, deal type and industry sector.
• wider coverage of Japanese deals courtesy of JCN

Partneringdesk Deals and Alliances helps in:
• the assessment of deal-making trends in the last five years
• identifying active partners
• tracking competitor activity
• benchmarking deals

	Therapy areas covered: (click 'more' for detailed synposis of each report (MS Word document)
	• Oncology - more... • Sensory and dental - more... • Genitourinary and gynecological - more... • Dermatological - more... • Blood and lymphatic - more... • Hospital, accident and trauma - more... • Infectious diseases - more...	• Cardiovascular - more... • CNS - more... • Auto-immune and inflammatory - more... • Metabolic - more... • Respiratory - more... • Gastrointestina - more...l • Musculoskeletal - more...

Price: $2495 or £1,385 for each therapy report
For further information about these reports, please contact Marianne O'Neill on +44 (0)1256 336632
or moneill@biopharmkp.com

Click here to order

Partneringdesk Deals Briefing

Partneringdesk Deals Briefing provides an in-depth view of deals made by more than 40 companies and their subsidiaries with partnering companies between 2001 and 2006, in a clear and accessible PDF format.

The reports contain:
• a brief company profile including subsidiary names
• financial information where disclosed
• a deals overview
• specialized indexes including deals by partner company, subsidiary company, therapy focus,
development stage, deal type and industry sector.
• a detailed listing of the company’s deals and alliances.

Partneringdesk Deals and Alliances helps in:
• identifying active partners
• tracking competitor activity
• benchmarking deals
• comparing the finances of different deal types.

	Companies covered: (click 'more' for detailed synposis of each report (MS Word document)
	• Abbot Laboratories - more... • Alcon Inc - more... • Allergen Inc - more... • Altana AG - more... • Angen - more... • Akzo Nobel - more... • Angen Inc - more... • Astellas Pharma - more... • AstraZeneca - more... • Barr Pharmaceuticals - more... • Baxter International - more... • Bayer AG - more... • Boehringer Ingelheim - more... • Biogen Idec - more... • Bristol Myers Squibb - more... • Daiichi Sankyo - more... • Dainippon Sumitomo - more... • Eli Lillly - more... • Essai Co Ltd - more... • Forest Laboratory - more... • Genzyme Corporation - more... • Gilead Sciiences Inc - more... • GlaxoSmithKline - more... • Johnson & Johnson - more... • H Lundbeck - more... • Medimmune - more...	• Medimmune - more... • Merck & Co - more... • Merck KGaA - more... • Mitsubishi Pharma - more... • Mylan Laboratories - more... • Novo Nordisk - more... • Ono Pharmaceuticals - more... • Otsuka Pharmaceuticals - more... • Novartis - more... • Pfizer - more... • Purdue Pharma - more... • Ranbaxy Laboratories - more... • Roche - more... • Sanofi-Aventis - more... • Schering AG - more... • Schering Plough Corporation - more... • Seronto SA - more... • Shire Plc - more... • Shionogi & Co Ltd - more... • Solvay SA - more... • Takeda Pharmaceutical - more... • Tanabe Seiyaku - more... • Teva Pharmaceutical - more... • UCB Pharma - more... • Watson Pharmaceutical - more... • Wyeth - more...

Price: £215 ($395) for each company report
For further information about these reports, please contact Marianne O'Neill on +44 (0)1256 336632
or moneill@biopharmkp.com

Click here to order

Partnering Review 2006

Want to know what your competitors are doing? Want to benchmark your deals against others in your therapeutic area or see how the finances of different deal types compare? Partneringreview 2006 brings all the 2005’s deals into focus in one place.

The reports contain:
• fully categorized overviews of deals, alliances and financings
• financial information where disclosed
• specialized indexes including deal type, therapy area, industry sector, financials and stage of development
• an alphabetical index of company activity
• interactive PDF format for easy exploration

This report will provide in depth knowledge of the deal making activity during 2005:
• Want to know what your competitors are doing?
• Want to benchmark your deals against others in your therapeutic area?
• See how the finances of different deal types compare?
• Want to know what the early, clinical and late stage developments are?
• Interested in new merger and acquisition activity over 2005?
• Curious about financing investments from lead investors?

	Reports available by Volume: (click 'more' for detailed synposis of each report (MS Word document)
	• Complete report - more... • Volume 1 - Deal index by company - more... • Volume 2 - Deal index by therapy area - more... • Volume 3 - Deal index by financing and investment - more... • Volume 4 - Deal index by development stage - more... • Volume 5 - Deal index by deal type - more... • Volume 6 - Deal index by industry sector - more...

	Reports available by Therapy or Sector: (click 'more' for detailed synposis of each report (MS Word document)
	• Academic - Deal index - more... • Accident - Deal index - more... • Autoimmune - Deal index - more... • Bioinformatics - Deal index - more... • Biotechnology - Deal index - more... • Blood - Deal index - more... • Cardiovascular - Deal index - more... • Central Nervous System - Deal index - more... • Clinical Stage - Deal index - more... • Collaborative R&D - Deal index - more... • Dermatology - Deal index - more... • Diagnostic - Deal index- more... • Discovery - Deal index - more... • Drug Delivery - Deal index - more... • Early Stage - Deal index - more... • Financing - Equity Investment - Deal index - more... • Financing - Grant - Deal index - more...	• Financing - IPO - Deal index - more... • Financing_Private_Placing - Deal index - more... • Financing Public Offer - Deal index - more... • Gastrointestinal.doc - Deal index - more... • Genitourinary - Deal index - more... • Infectious Diseases - Deal index - more... • Late Stage - Deal index - more... • Licensing - Deal index - more... • Marketing Promotion - Deal index - more... • Medical Devices - Deal index - more... • Metabolism - Deal index - more... • Onology - Deal index - more... • Pharmaceutical - Deal index - more... • Repiratory - Deal index - more... • Research Tool - Deal index - more... • Sensory Organ - Deal index - more... • Supply Distribution - Deal index - more...

Prices:
Complete package is $3995 or £2,220
Volumes 1 - 6 are $2495 or £1,385 each
Reports by Therapy or Sector is $795 or £440.
For further information about these reports, please contact Marianne O'Neill on +44 (0)1256 336632
or moneill@biopharmkp.com

Click here to order

For further information about this report, please contact Marianne O'Neill on +44 (0)1256 336632
or moneill@biopharmkp.com

Click here to order